Skip to main content
NEOGNeogen CorporationSell5.7·$12.19
NEOG · Concentration risk · 10-K extracted

Neogen (NEOG) concentration risks

Updated

The most significant concentration Neogen discloses is sole or single source raw materials and products, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Neogen’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 2 disclosed concentrations

HIGH1
MEDIUM1
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHOutside partySupplier

sole or single source raw materials and products

“10-K Item 1A: 'we currently purchase some raw materials and products from sole or single sources'”
— SEC 10-K · filed Jul 2026
MEDIUMOutside partySupplier

3M plants manufacturing Petrifilm

“10-K Item 1: 'Petrifilm product line are currently manufactured within 3M plants in the U.S. and Poland'”
— SEC 10-K · filed Jul 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-10-18

Neogen's disclosed concentrations are both on the supply side and carry no stated percentages. The company purchases some raw materials and products from sole or single sources, a high-share dependency. Separately, the Petrifilm product line is currently manufactured within 3M plants in the U.S. and Poland, a medium-share dependency tied to a named counterparty. The two exposures are distinct but compound: the sole-source inputs create a general interruption risk, while the 3M arrangement concentrates one product line on a single outside manufacturer and its two sites. Both are dependencies in character, so they are counterparty-specific and idiosyncratic rather than structural features of the business. Because the sources give no percentages, the size bands reflect disclosure language rather than quantified revenue at risk, and the financial impact of a disruption cannot be read from them. The sources identify no customer or geographic concentration that would add to or offset these. On balance, supplier continuity is the item most likely to move the verdict.

For the engine’s reasoning on NEOG’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Devices

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
AORTArtivion, Inc.4408
ATECAlphatec Holdings, Inc.1102
NEOG●Neogen Corporation1102
ABTAbbott Laboratories1001
AVRAnteris Technologies Global Cor1001
AHCOAdaptHealth Corp.0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home › Stocks › NEOG › Concentration risk
NEOG concentration risks — customer, geographic & supplier exposure | TrendMatrix